Feed on
Posts
Comments

The FDA recently approved the release of a new drug for the treatment of schizophrenia and bipolar disorder in adult patients. The newly approved drug called Saphris (asenapine) belongs to a class of drugs known as atypical antipsychotics. The drug is an important addition to the product portfolio of the Schering-Plough, which, in March 2007 [...]

Read Full Post »

"> ">